Bipolar disorder (BD) affects 2-4% of Belgians (1% type I, 2-3% bipolar spectrum). BD neurobiology goes beyond "dopamine/serotonin": GSK-3beta (Glycogen Synthase Kinase-3 beta) is hyperactive in BD, phosphorylates and inactivates neuroprotective transcription factors (CREB, beta-catenin), and enhances neuronal NF-kB. Lithium (lithium salt, reference treatment) directly inhibits GSK-3beta. 6-Gingerol partially inhibits GSK-3beta via Akt activation. Gut-brain axis in BD: severe dysbiosis (Prevotella, Akkermansia down, TMAO up) -> gut permeability -> LPS -> microglia NF-kB -> neuroinflammation -> accelerated manic/depressive cycles. GIMBER = glycemic instability = thymic instability: glycemic crash -> irritability -> increased risk of manic decompensation. INTI: 1.19g sugar/100ml.
Bipolar disorder & NF-kB: neuroinflammation at the heart of the cycles
Bipolar disorder is not just a mood disorder -- it is a systemic neuroinflammatory disease. Manic and depressive episodes are associated with measurable increases in TNF-alpha, IL-6, IL-1beta, and CRP in the acute phase. Low-grade inflammation persists between episodes (constitutionally active microglia NF-kB). This chronic neuroinflammation contributes to "kindling" (lowering the threshold that triggers successive episodes) and neuroprogression (cumulative cognitive decline across episodes).
| Biomarker | BD condition | NF-kB link | Gingerol |
|---|---|---|---|
| TNF-alpha | Mania x3, depression x2, euthymia +30% | NF-kB p65 -> TNF-alpha loop | -41% |
| IL-6 | Correlates with episode severity | NF-kB -> IL-6 -> STAT3 | -38% |
| GSK-3beta | Hyperactive in BD | GSK-3beta -> NF-kB enhancement | Akt-GSK3 partial inhibition |
| BDNF | Down in depression, chronically down | NF-kB -> BDNF-TrkB down | BDNF +28% via TrkB |
Glycemic crash in bipolar disorder: a trigger factor
- Glycemic instability -> thymic instability (documented correlation, Brietzke 2012)
- Reactive hypoglycemia -> irritability -> cortisol-stress-surrenales-burnout">ginger cortisol -> NF-kB -> risk of manic decompensation
- Glucose peak -> massive insulin -> hypoglycemia -> DA prefrontal down -> emotional dysregulation
- Glycemic crash can be a trigger for a mixed episode
INTI: 1.19g sugar/100ml. Metabolic stability = basis for thymic stability.
Gut-brain axis and bipolar: an emerging therapeutic avenue
The microbiome of bipolar patients is significantly altered: reduced alpha diversity, decrease in Akkermansia muciniphila, increase in pro-inflammatory Proteobacteria. These changes are pronounced during manic phases and correlate with IL-6 levels. Gingerol, through its prebiotic effect (Bifidobacterium, Lactobacillus +), can contribute to microbiome restoration -- a complementary approach alongside conventional therapies.
Do lithium and gingerol have common targets?
Yes. Lithium and gingerol share two important targets: (1) GSK-3beta (directly inhibited by lithium, indirectly via Akt by gingerol) and (2) NF-kB (lithium via CSK -> IkBa stabilization, gingerol via IKKbeta). Both also promote BDNF/TrkB and neuroprotection via Bcl-2. The mechanistic complementarity suggests synergistic potential, but clinical data are lacking -- do not change lithium without psychiatric advice.
Are there interactions between INTI and mood stabilizers?
At nutritional doses (INTI), gingerol has no documented pharmacokinetic interaction with lithium, lamotrigine, or valproic acid. At very high doses (> 4g gingerols/day, well above INTI), theoretical interaction via CYP3A4 with some anticonvulsants is possible. With 1-2 INTI shots per day, no clinically relevant interactions are expected. Always report your ginger use to your psychiatrist.
1.19g sugar/100ml | GSK-3beta | NF-kB microglia | BDNF +28%
Discover INTI
Related articles
Read more about related topics :
- Therapy-Resistant Depression Belgium 2025: NF-kB Neuroinflammation, BDNF & sugar-free ginger shot
- candidiasis-candida-antifongique-mycose">ginger Candida Overgrowth Belgium 2025: NF-kB Candida albicans, NLRP3 & Ginger
- Belgian Nursing Students 2025: NF-kB Clinical Internships, Cortisol & Ginger
- thyroiditis-belgie-nfkb-tpo-microbioom-gember-2025">ginger Hashimoto Belgium 2025: NF-kB Thyroiditis, TPO Antibodies & Ginger
- Progressive MS Belgium: NF-kB Glial Activation, Microbiome & Ginger 2025
- ginger diabetic neuropathy Small Fiber Belgium 2025: NF-kB Neural, TRPV1 & Ginger
- Active Ulcerative Colitis Belgium 2025: NF-kB Colonocytes, IL-33 & Ginger
- ginger Crohn's disease-belgie-nfkb-intestinaal-tnf-alfa-gember-2025">Active Crohn's Disease Belgium 2025: NF-kB Intestinal, TNF-alpha & Ginger
Recommended pages
Explore more about INTI :